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Abstract: A fluorescent probe based on bovine serum albumin stabilized copper nanoclusters (BSA-CuNCs) was developed for the
selective and sensitive determination of ornidazole (ORN). The nanoclusters were synthesized via a one-pot hydrothermal process in
basic media. The synthesized and characterized BSA-CuNCs have less than 3 nm particle size and exhibited blue emission at 405 nm
when excited at 325 nm. Synthesized and characterized nanoclusters were successfully applied as a turn-off fluorescent probe for the
determination of ORN in pharmaceutical dosage forms. The quenching mechanism created an was inner filter effect (IFE). The method
was linear in the concentration range of 0.52–13.56 μg mL–1 with a low limit of detection (LOD) 0.01 μg mL-1. High recovery values
(98.5%–102.42%) with low RSD% values (0.25%–2.73%) were obtained. The synthesized nanoclusters can be used as a turn-off probe
for ORN determination with their selective, simple, rapid, and inexpensive properties.
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1. Introduction
Ornidazole, ORN, (1-(3-chloro-2-hydroxy)propyl-2-methyl-5-nitroimidazole or 1-chloro-3-(-2- methyl-5-nitroimidazole1-yl)propan-2-ol) is a member of third-generation nitroimidazole [1–3] ORN, which has antiprotozoal and antibacterial
properties, shows selective activity against anaerobic, microaerophilic bacteria, and protozoa such as Trichomonas and
Entamoeba species [2,4]. Therefore, it is used in the treatment of infections such as trichomoniasis, amebiasis, and giardiasis,
Helicobacter pylori duodenal ulcers, metronidazole-resistant strains of Trichomonas vaginalis and for prophylaxis
in dental and gastric surgery operations [3–5]. Compared to previous nitroimidazoles, ORN has a longer half-life and
correspondingly less frequency of dosing. However, the side effects of ORN are mainly nausea, abdominal pain, vomiting,
spermatotoxicity, genotoxicity, genomic instability, central nervous system toxicity, and ornidazole-induced autoimmune
hepatitis [2]. Analysis of ORN from human plasma, pharmaceutical dosage forms, and other samples have been done
with different techniques; these were capillary electrophoresis [4], high performance liquid chromatography (HPLC) used
different detectors such as UV [5] and mass spectrometry [6], luminescence spectroscopy [7], and electrochemistry [8].
Although mentioned methods are commonly used and sensitive, they have disadvantages such as low repeatability, need
time-consuming sample preparation steps, high operating cost, and need for expert staff. For this reason, a new sensitive,
selective, repeatable, simple applying, time-saving, and cheap method for the determination of ORN is needed.
Metal nanoclusters and quantum dots, which are luminescent materials, are very promising compared to organic
molecules. However, the use of quantum dots in biological studies can be toxicologically dangerous due to the heavy
metals they contain [9, 10]. Metal nanoclusters consisting of several to hundred atoms, they display properties similar to
molecules such as spectrochemical and redox properties, magnetism, the HOMO-LUMO transition [11–18]. The most
well-known metal nanoclusters (MNCs) are gold (AuNCs), silver (AgNCs), and copper (CuNCs), which are attractive
with their size less than 2 nm; on the other hand, the overall size of NCs can be larger with the adding of protective
groups to the cluster core [17–20]. Metal nanoclusters have unique features such as low toxicity, quantum-size effect,
high photoluminescence efficiency, high stokes shift, water-solubility, photostability, and easy synthesis procedures.
Thus, fluorescent metal nanoclusters are used in a broad applications area in various fields such as sensing, biosensing,
ion sensing, bio-labeling, single-molecule imaging, chemical catalysis, and pharmaceutical analysis [11–14]. In these
studies, because of the interaction of analyte and nanoclusters, the photoluminescence properties of nanoclusters such
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as luminescence spectrum and/or lifetime change. ---In these studies, the photoluminescence properties of nanoclusters
such as luminescence spectrum and/or lifetime change due to the interaction of analyte and nanoclusters. Gold, silver,
and copper nanoclusters were generally used for their biocompatible features in these studies. Among them, the synthesis
of copper nanoclusters is more economical and easier compared to gold and silver nanoclusters [15]. Different synthesis
methods are developed to form nanoclusters based on chemical or photoreduction, chemical etching, ultrasound, and
microwave [16]. Some of these methods are using harmful chemicals and needed complicated instruments. Surface ligands
not only stabilize NCs but also have a significant effect on their fluorescence properties. Ligands act as a stabilizer that
controls the size of NCs, while at the same time, altering the surface function of NCs and, accordingly, their fluorescence
properties. DNA, proteins, amino acids, peptides can be used as a template for copper nanoclusters [17]. Recent reports
showed that fluorescent copper nanoclusters can be created by proteins from the corresponding metal precursor salt as a
precursor. In these studies, bovine serum albumin (BSA), a well-known blood protein, was used forming and stabilizing
agent to compose sub-nanosize copper clusters based on reducing Cu precursors.
In addition, BSA has an important place because it has a strong affinity for inorganic metal ions and small molecules,
as it contains disulfide bonds and one free cysteine [1]. Besides, the use of BSA as a template also significantly affects the
fluorescence properties of CuNCs, which have blue or red emission depending on the synthesis method.
In here, the blue-emitting fluorescent BSA capped copper nanoclusters (BSA-CuNCs) were synthesized via a one-pot
hydrothermal process without using any organic, strong reducing agents, and additional stabilizers. Synthesized CuNCs
were characterized with different methods such as transmission electron microscopy (TEM), infrared spectroscopy (FTIR), UV-visible (UV-vis), fluorescence, and X-ray photoelectron spectroscopy (XPS), dynamic light scattering analyses
(DLS), and zeta potential measurement. In addition, pre-synthesized NCs were used for the determination of ORN in
pharmaceutical dosage forms as a turn-off fluorescent probe. Although there was one study based on using only BSA to
determine the ORN [21], in previous studies, the determination of ORN based on interaction with CuNCs in different
pharmaceutical forms has not been reported, so the proposed method has a novelty in this field. The developed method
has a low detection limit, which indicates the sensitivity of the method and also is repeatable, fast, simple, inexpensive,
and eco-friendly.
2. Experimental
2.1. Chemicals and materials
Ornidazole (ORN), sodium hydroxide, and bovine serum albumin (BSA) were obtained from Sigma–Aldrich Chemical
Co. (USA) and used as received without purification. Copper nitrate, phosphoric acid, potassium sulphate, sodium
chloride, magnesium chloride, sodium carbonate, potassium nitrate were analytical reagent grades and purchased from
Merck (Darmstadt, Germany). The pharmaceutical samples were provided from local pharmacies in Ankara, Turkey. All
samples were kept and analyzed at room temperature. Stock ORN solution (1.0 ´ 10–3 mol L–1) was prepared in deionized
water and kept in the refrigerator until analyzing.
Phosphate buffer solutions with different pH values (pH = 2–11; 0.1 M) and sodium hydroxide solution (0.4 M) were
prepared using analytical grade reagents and in deionized water. Sodium hydroxide (5 M) was used to adjust the pH value
of the buffer solutions. Water used throughout was deionized water (>18 MW .cm).
2.2. Instrumentation
In order to obtain TEM images, FEI Tecnai G2 Spirit Biotwin CTEM was used. For FT-IR studies Perkin Elmer Spectrum
400 FTIR / FTNIR spectrometer equipped with a Universal ATR Sampling Accessory (Perkin Elmer Inc., Waltham, Ma,
USA) was used and, spectra were reported in cm–1. X-ray photoelectron spectroscopic (XPS) analyses were made by
using PHI 5000 VersaProbe III multi technique XPS (ULVAC-PHI, Japan). Zeta potential and dynamic light scattering
(DLS) analysis were done on a Zetasizer Nano ZS Series, Malvern instrument. UV-Vis spectra were obtained with Specord
50 Plus (Analytik Jena, Germany). Fluorescence measurements were carried out by using the Agilent Cary Eclipse
spectrofluorimeter. The excitation wavelength was set at 325 nm and slits were 10.0 nm. Quartz cells with 10 × 10 mm
path length were used for all spectroscopic measurements. pH measurements were done with a Mettler-Toledo GmbH
(Greifensee-Switzerland) pH meter. All experiments were carried out at room temperature.
2.3. Synthesis of BSA stabilized CuNCs
Synthesis of BSA stabilized CuNCs were made by minor modification according to the method of Goswami et al [22].
Briefly, 1 mL, 20 mM aqueous Cu(NO3)2.3H2O was taken into the beaker. Then 5 mL, 15 mg/mL BSA solution was added
to this solution and stirred for 3 min at room temperature. After the mixing step, the pH value was adjusted to 12 by
adding NaOH. Upon reaching a pH value of 12, the color of the solution changed from pale green to purple. Finally, the
mixture was stirred vigorously at 55° C for 7 h. After that time the color of the solution changed to light brown, synthesized
nanoclusters were stored in the refrigerator.
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2.4. Analysis of pharmaceutical dosage forms
In this study, ORN was determined in different pharmaceutical dosage forms such as tablets and injection forms.
To prepare tablet samples, ten tablets containing ORN were weighed and powdered finely in a mortar. An appropriate
amount of powder was weighed accurately, taken into the volumetric flask, and diluted with deionized water. Then, it was
sonicated for 30 min and centrifuged for 10 min. The obtained supernatant was used for the measurements.
In order to prepare the injection from the sample for injection, 20 µL of the sample was taken and completed with 10
mL of deionized water in the flask, then vortexed for 1 min.
2.5. Interaction between ORN and BSA stabilized copper nanoclusters
Before interaction studies, the effect of pH on ORN and BSA-CuNCs was examined. For this purpose, phosphate buffer
solutions at different pH values (pH = 2–12; 0.1 M), and 0.1 M NaOH solution (pH = 13) values were tested.
In order to evaluate of interaction between ORN and BSA-CuNCs, a 2.0 mL 0.1 M pH 12 phosphate buffer solution
containing an appropriate concentration of BSA-CuNCs was added into the quartz fluorescence cell, and then it was
titrated by successive additions of a stock solution of ORN. Titration was done by using a micropipette manually. The
fluorescence emission spectra were recorded in the wavelength range of 335–500 nm with an exciting wavelength at 325
nm in the presence and absence of ORN.
The fluorescence intensity changing of nanoclusters as a result of interaction was determined using the ratio of
fluorescence intensities of CuNCs in the absence (F0) and the presence of ORN (F). All measurements were done with
three replicates, and for the calculations obtained, average values were used.
2.5. Selectivity studies
In order to evaluate possible interference coming from excipients in pharmaceutical dosage forms and the selectivity of
the proposed method, selectivity studies were done. For this purpose, the effect of some possible commonly interfering
ions such as potassium, sodium, magnesium, chloride, sulphate, carbonate, nitrate, and excipients such as propylene glycol
and ethanol in injection form, starch, and magnesium stearate in tablets on the fluorescence emission intensity of BSACuNCs was examined. In this study, the concentrations of ORN and interferents were 36 µM and 360 µM, respectively.
The fluorescence emission values of nanoclusters were recorded by adding both ORN and interfering ions/molecules
separately on BSA-CuNCs.
3. Results and discussion
3.1. Characterization of BSA stabilized copper nanoclusters
BSA stabilized CuNCs were prepared based on the reduction of copper salts by BSA in the alkaline aqueous solution via the
one-pot hydrothermal method. The amino acid residues, which are cysteine, histidine, and tyrosine in BSA, play important
and different roles in creating the nanoclusters. The first two of these amino acids can coordinate with metal ions, while the
last one can reduce metal ions to form metal NCs. The physical/chemical structure and optical features of prepared BSACuNCs were evaluated by using TEM analysis, zeta potential and dynamic light scattering measurements, and different
spectroscopic techniques such as UV-vis, fluorescence spectroscopy, and XPS. The TEM image showed that the BSACuNCs were in a well-dispersed spherical shape with an average diameter of 2.1 nm particle size, and their distribution
was uniform (not shown). Additionally, 3.6 nm particle size, the slightly larger size due to the hydrodynamic radius, was
obtained from dynamic light scattering analysis, which was in agreement with TEM analysis (Figure 1A). Moreover, the
results of zeta potential analysis showed that synthesized BSA-CuNCs have a negative and high zeta potential value of −31.5
mV in the working buffer solution (pH value at around 12). This negative value represents synthesized nanoclusters have
negatively charged and protected the copper nanoclusters from aggregation. The stability studies showed that synthesized
nanoclusters were stable for at least 2 months without considerable precipitation in the refrigerator at 4°C.
In order to identify the changing of surface groups, the FT-IR spectra of BSA and BSA-CuNCs were recorded (Figure
1B). As shown from the figure, in BSA spectra, the three peaks corresponding to -NH bending (1530 cm–1), -CN stretching
vibrations (1230 cm–1), and amine scissoring (1640 cm–1) were observed. Moreover, the bending vibrations peak attributed
to the -OH group in carboxylic acids was observed at 1385 cm–1. Similar peaks at 1598 cm–1 and 1300 cm–1 related to -NH
bending and -CN stretching were observed in the BSA-CuNCs spectrum indicating interaction with CuNCs and BSA.
Besides, -NH scissoring peak was disappeared, which can be explained by the reaction of -NH group with copper during
the formation of CuNCs. In addition to these results, although pure BSA has a peak at 280 nm, a weaker peak at 325 nm
appears after synthesis of BSA-CuNCs, which can prove the formation of new material in the synthesized environment
(Figure 2).
The XPS survey was introduced to explore the components of BSA stabilized CuNCs, and five major peaks at 162, 284,
398, 530, and 932 eV related to S 2p, C 1s, O 1s, N 1s, and Cu 2p were observed (Figure 1C).
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Figure 1. (A) Dynamic light scattering result of BSA-CuNCs, (B) FT-IR spectrum of BSA (red
line) and BSA-CuNCs (blue line), (C) The survey XPS spectrum of BSA-CuNCs.
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Figure 2. UV–vis absorption (a) and fluorescence emission (b) spectra of BSACuNCs, absorption spectra of ORN (c) and BSA (d).

In order to evaluate the spectroscopic character of the synthesized BSA stabilized CuNCs, Uv-vis and fluorescence
spectra were recorded. Absorption spectrum showed that (Figure 2) no plasmonic absorption peak was observed at the
visible wavelengths. This result approves the absence of larger copper nanoclusters in synthesis media. To investigate the
fluorescent properties of the synthesized BSA stabilized CuNCs, excitation and emission spectra were recorded, and they
showed a maximum emission peak at 405 nm when excited at 325 nm.
3.2. ptimization of CuNCs synthesis conditions
In this work, BSA was used as a stabilizer for the preparation of CuNCs. Cu2+ ions and BSA formed a complex through
electrostatic binding and coordination interactions owing to functional groups of BSA such as –NH2, -SH. The effect of
reaction time, the concentration of metal ion, and pH value were examined to define the optimum synthesis conditions.
In order to determine the effect of copper ion concentration, different volumes of copper ion solution were examined.
As shown in Figure 3, the emission of clusters is dependent on various metal ion concentrations, and emission reduction
occurs as nanoparticles are formed at higher metal ion concentrations. The second key parameter to obtain a high
concentration of BSA-CuNCs was pH value. For this purpose, phosphate buffer solutions with different pH values and
NaOH solution were examined (Figure 4). Obtained results show that higher fluorescence emission intensity was obtained
for the reaction with 3.33 mM Cu(NO3)2 solution at pH = 12, and this pH was selected. Another crucial step was the
mixing time of nanoclusters, which affected the fluorescence properties of BSA-CuNCs. Therefore, the effect of mixing
time on the fluorescence emission intensity of BSA-CuNCs from 0 to 7.5 h was examined. As seen from Figure 5, the
maximum intensity was obtained at 7th h. The emission signal of BSA-CuNCs decreased after this time, this may be
due to overgrowth or aggregation. The experimental results proved this hypothesis because the longer incubation time
precipitation occurred, and the color of BSA-CuNCs changed to dark brown.
3.3. The selections of experimental conditions
In order to identify optimum experimental conditions, the effect of different parameters such as pH value and incubation
time on the luminescence of BSA-CuNCs were examined. The obtained results showed that the fluorescence emission of
BSA-CuNCs was pH-dependent. As seen from Figure 6A, at the basic area, high emission signal was achieved. This can
be attributed to an increase of pair of electrons of BSA at basic pH value, while, at acidic medium, the neutralization of
negatively charged BSA-CuNCs was occurred due to high proton concentrations. Therefore, followed experiments were
carried out at pH = 12.
The effect of incubation time was also identified from 0 to 5 min, and there was no difference in emission signal after
1 min. Hence, reaction time was chosen as 1 min as the experimental condition (Figure 6B). All optimization figures were
given with error bars (Standard deviation, SD, and n=3).
3.4. Selectivity of method
The selectivity of the nanoclusters for the detection of ORN was also evaluated. The effect of excipients such as propylene
glycol and ethanol in injection form, starch and magnesium stearate in tablets, and different ions such as K+, Na+, Mg2+,
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Figure 3. The effect of copper ion concentration on fluorescence emission of BSACuNCs. The final metal ion concentrations were 1.81 mM, 2.60 mM, 3.33 mM, and
4.61 mM at keeping BSA concentration at same BSA concentration, i.e. 15 mg/mL.
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Figure 4. Photoluminescence spectra for BSA-CuNCs synthesized at different pHs
values (3-13)

Cl-, SO42-, CO32-, and NO3- were tested under optimized experimental conditions. The fluorescence emission of the BSACuNCs was measured at 405 nm. The ORN concentration was 36 mM, and excipients / metal ion concentration was
360 mM. As seen from the bar diagram of the fluorescence intensity change (Figure 7), only ORN showed a remarkable
quenching of the BSA-CuNCs fluorescence, while the other interfering molecules and ions did not cause a significant
response.
3.5. Fluorescence quenching mechanism
BSA stabilized CuNCs have excellent chemical and spectroscopic properties such as simple synthesis procedure, suitability
to green chemistry, high and stable emission, low toxicity; hence, in this study, they were chosen to be the fluorescent probe
for the determination of ORN in pharmaceutical formulations.
The change in the fluorescence spectra of BSA-CuNCs with successive additions of ORN were shown in Figure 8. It
can be seen from the Figure the fluorescence intensity of BSA-CuNCs was effectively quenched when the concentration of
ORN increases, indicating an interaction between ORN and BSA-CuNCs. The previous study has also shown that the ORN
has interacted with tyrosine residues of BSA molecules via hydrophobic and electrostatic forces [21].
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Figure 5. Effect of mixing time on fluorescence emission of BSA-CuNCs.
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Figure 6. Effect of pH value and incubation time on fluorescence emission of BSACuNCs.
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Fluorescence quenching mechanisms can occur in several ways: static and dynamic (collisional) quenching, inner filter
effect (IFE), and fluorescence resonance energy transfer (FRET). In static and dynamic processes, the fluorophore and
the quencher should interact at the ground or excited state. In a static quenching system, both molecules compose a nonfluorescent molecule at the ground state, while in the dynamic (collisional) quenching process, quenchers and fluorophores
are interacting in the excited state. Both of them can cause nonradiative relaxation and a decrease in fluorescence emission.
The fluorescent resonance energy transfer (FRET) mechanism describes the energy transfer between two light-sensitive
molecules, defined as donor and acceptor. For the IFE mechanism to occur, the absorption spectrum of the quencher
and the excitation or emission spectrum of the donor must overlap. All these mechanisms can occur simultaneously and
competitively.
Figure 2 shows the great overlapping between the absorption spectra of BSA-CuNCs and ORN. UV–Vis absorption
spectra of BSA-CuNCs in the presence of ORN were also recorded, and no observable variation was obtained. Moreover, it
was noticed that there was a small part of overlap between the emission band of CuNCs and the absorption peak of ORN,
which may mean the reabsorption of the NCs emission by ORN. According to Beer–Lambert Law, the molar absorption
coefficient of ORN was calculated as 1.9 × 104 at 325 nm wavelength, which demonstrated that it was applicable to sensitive
determination by IFE.
In addition, as seen from Figure 8, the fluorescence emission signal of BSA-CuNCs was quenched by adding ORN.
Based on the above explanation, this decrease in signal is due to the filtering effect. However, as mentioned earlier,
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Figure 8. The effect of ORN concentration on fluorescence emission of the
BSA-CuNCs. ORN concentration was in the range of 2.35–61.70 µM at pH=12
phosphate buffer (from top to bottom, the dotted line is QDs alone). The inset
shows the change of the fluorescence intensity with the increase of the ORN
concentration.

other quenching mechanisms can also happen simultaneously. Stern–Volmer equation defines both static and dynamic
quenching mechanisms according to the following formula (Eq. 1) [23].
F0 / F = 1 + KSV [Q]
[1]
where F0 and F indicate the fluorescence intensities of BSA-CuNCs before and after the interaction with ORN,
respectively. KSV is the Stern–Volmer quenching constant, and [Q] is the concentration of the ORN. KSV is determined by
the slope value of the linearity plot of the F0/F and [Q].
A good linearity was obtained in the range from 2.35 to 61.70 µM with the regression coefficient of r = 0.9910 and
equation F0 / F = 0.02 [Q] + 0.92 (Figure 4 inset). The obtained results indicated that the static quenching process occurred
between the ORN and CuNCs system, and KSV was calculated to be 1.96´104 M–1, which shows that interaction between
drug and BSA-CuNCs is strong. These results showed that the synthesized nanoclusters can be applied as a fluorescent
probe to determine ORN in pharmaceutical samples.
For better identification of the quenching mechanism, Eq. (2) was used to calculate the dynamic fluorescence quenching
rate constant, Kq,
Kq= KD/τ0
[2]
where τ0 is the average lifetime of the fluorophore in the absence of quencher, and the value of τ0 is 10–8 s for the
biopolymer. For collisional quenching, the maximum scattering dynamic quenching constant of various quenchers is
2.0´1010 mol L–1 s–1. On the other hand, the Kq value was calculated as 1.96´1012 mol L–1 s–1, which is greater than the
maximum dynamic quenching constant suggesting that there is a nonfluorescent complex formed between the drug and
nanoclusters [24]. This result confirms the static quenching mechanism. The site binding model is used to define the
number of binding sites (n) and binding constant (K) of ORN with BSA-CuNCs, Eq. (3).
log ((F0 / F)/F) = log K + n log [Q]
[3]
These values can be determined by the intercept and slope values of the regression plot of log(F0–F)/F vs. log[Q]. The n
and K were found as 1.2 and 2.87´105 M–1, respectively. The high binding constant indicated a higher affinity between ORN
and BSA-CuNCs. The binding constant (K) was also calculated with the Benesi–Hildebrand equation (4).
A0/( A - A0)= εNCs /( εORN - εNCs) + εNCs /( εORN - εNCs) × 1/K [ORN]
(4)
where A0 and A are the absorbance values of BSA-CuNCs before and after added of ORN, respectively. εNCs and εORN
are the molar absorption coefficients of BSA-CuNCs and their complex with ORN, respectively. In accordance with Eq.
(4), the plot of A0/(A–A0) against 1/[ORN] was constructed using the data from the spectrophotometric titrations, and a
linear fitting of the data yielded the binding constant (K), which was 3.04´105 M–1 for ORN-CuNCs. The binding constants
obtained from fluorescence and UV-vis experiments were compatible.
The degree of repulsion between the similar charges present on the particle surface was described with Zeta potential,
and this force keeps the particle from aggregation and, thereby, increases the stability of particles. The measured zeta
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potential values of prepared particles were –31.5 mV and −15.8 mV in the absence and the presence of ORN, respectively,
which might indicate the aggregation of nanoparticles.
3.6. Detection of ORN in pharmaceutical forms
The proposed sensor was then applied for the quantitative analysis of ORN in pharmaceutical samples. The good linear
correlation obtained using the sensor was achieved in the range of 0.52 to 13.56 μg mL−1 with an r value of 0.9934. The linear
regression equation was F0/F = 0.095 C (μg mL–1) + 0.91. The good linearity of the calibration graph and the negligible
scatter of experimental points were evaluated by the values of the correlation coefficient and standard deviation values.
Several approaches are given in the ICH guidelines to determine the limit of detection (LOD) and limit of quantification
(LOQ). Limit of detection (LOD) and limit of quantification (LOQ) values were calculated according to the ICH guidelines
by using equations 3 s/m and 10 s/m, where s is the standard deviation of the response, and m is the slope of calibration
graph, respectively [25]. LOD and LOQ values were found as 0.01 μg mL–1 and 0.04 μg mL–1, respectively. In order to evaluate
the repeatability and reproducibility of the proposed method, fluorescence intensities of five replicates were measured in
the same (intraday precision) and following three days (inter-day precision). The values of inter- and intra-day precision
were found as 0.24 and 0.65, respectively. The results summarized in Table 1 indicate a high degree of precision for the
proposed method. As indicated by the results (Table 1), the proposed method has a wide dynamic range, good accuracy,
and a low detection limit. Hence, it allowed using quantitative determination of ORN in its pharmaceutical forms such
as tablets and ampoules. Obtained results have good agreements with labeled values (Table 2). Recovery studies were
Table 1. Regression and validation parameters of ORN by using
BSA-CuNCs as a fluorescent probe.
Linearity range (µg mL–1 )

0.52–13.56

Slope

0.095

Intercept

0.91

Correlation coefficient

0.9934

SE of slope

9.17´10-3

SE of intercept

0.02

LOD (µg mL )

0.01

LOQ (µg mL–1)

0.04

Intra-day precision (RSD%)

0.24

Inter-day precision (RSD%)

0.65

–1

SE: Standard error
RSD: Relative standard deviation
LOD: Limit of detection
LOQ: Limit of quantitation
Table 2. Dosage form and recovery analysis of ORN.
Tablet (%)

Ampoule (%)

99.70
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101.06

103.40

Mean 99.04

100.24

Mean 100.63

96.95

RSD % 2.73

100.56

RSD % 0.25

95.51

100.64

99.63

100.64

Added (µg mL–1)

Found (µg mL–1)

Recovery (%)

1.65

1.69

102.42

3.3

3.25

98.50

4.95

4.90

99.00
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Table 3. Comparison of the proposed method with different techniques reported for the determination of
ORN.
Method

Linear range
(μg mL–1)

LOD
(μg mL–1)

Recovery (%)

Ref.

Capillary electrophoresis

25–250

1.80

96.2–105.2

4

HPLC

0.03–5.08

0.01

99.5–104.1

LC-MS

0.03–10.0

0.03

96.5–102

5
6

Fluorescence-Graphene QD

0.16–6.59

0.05

104.5

7

Electrochemical

0.15–22.1
22.1–54.9

0.05

99.3–100.4

8

Fluorescence

0.40–80

0.11

99.7–100.8

21

Fluorescence-BSA-CuNCs

0.52–13.56

0.01

98.5–102.4

This work

performed in order to prove the accuracy of the proposed method, by adding samples in an appropriate amount of stock
solution of ORN. The recovery values were in the range of 98.50%–102.42% (Table 2). These high recovery values proved
the accuracy of the developed method. The proposed method has sensitivity and accuracy for determination from the
pharmaceutical dosage forms. Our proposed approach was compared with other separation methods such as capillary
electrophoresis [4], HPLC [5], LC-MS [6], fluorescence [7, 21], and electrochemical techniques [8] for the determination
of ORN with respect to linear range, LOD, and recovery (Table 3). As seen from the table, the BSA–Cu NCs sensor has a
wide linear range, high recovery, low detection limit value, and simplicity when compared with the previous studies. Thus,
it holds great practicality for ORN detection in real pharmaceutical samples.
4. Conclusion
In this paper, the water-soluble fluorescent BSA-CuNCs were synthesized based on the reaction of copper ions and BSA
in basic media by a one-pot hydrothermal process. The obtained results showed that fluorescence of BSA-CuNCs could be
quenched due to the IFE mechanism between ORN and NCs. Synthesized and characterized nanoclusters were successfully
applied as a fluorescence probe for the determination of ORN in pharmaceutical forms. High recovery values (98.50%–
102.42%) with low RSD% values (0.25%–2.73%) were achieved. The proposed method can be used as a promising tool for
ORN analysis with its selective, selective, simple, rapid, and inexpensive properties.
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